ClinicalTrials.Veeva

Menu

The Oxygenation of the Brain During Caesarean Section (OBDUC)

N

Naestved Hospital

Status and phase

Completed
Phase 4

Conditions

Complications; Cesarean Section

Treatments

Drug: Phenylephrine
Drug: Ephedrine

Study type

Interventional

Funder types

Other

Identifiers

NCT01509521
SJ-271 (Other Identifier)
2011-006103-35

Details and patient eligibility

About

The purpose of this study is to determine the impact of phenylephrine versus ephedrine on organ perfusion, in women undergoing caesarean section receiving spinal anaesthesia. The organ perfusion is estimated by measuring the maternal cerebral oxygenation by NIRS(Near-infrared spectroscopy)and the foetal heartrate.

Enrollment

24 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy pregnant women
  • Over 18 years old
  • ASA 1-2
  • Undergoing elective caesarean section
  • Height over 160 cm or under 180 cm

Exclusion criteria

  • Allergic reactions to ephedrine or phenylephrine
  • High blood levels of bilirubin
  • HELPP syndrome
  • Preeclampsia (pregnancy-induced hypertension)
  • Non singleton pregnancies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Ephedrine
Active Comparator group
Treatment:
Drug: Ephedrine
Phenylephrine
Active Comparator group
Treatment:
Drug: Phenylephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems